Artykuły w czasopismach na temat „Atypical Chemokine Receptors”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Atypical Chemokine Receptors”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Hansell, C. A. H., C. V. Simpson, and R. J. B. Nibbs. "Chemokine sequestration by atypical chemokine receptors." Biochemical Society Transactions 34, no. 6 (2006): 1009–13. http://dx.doi.org/10.1042/bst0341009.
Pełny tekst źródłaBorroni, Elena M., Raffaella Bonecchi, and Annalisa M. VanHook. "Science Signaling Podcast: 30 April 2013." Science Signaling 6, no. 273 (2013): pc11. http://dx.doi.org/10.1126/scisignal.2004231.
Pełny tekst źródłaGroblewska, Magdalena, Ala Litman-Zawadzka, and Barbara Mroczko. "The Role of Selected Chemokines and Their Receptors in the Development of Gliomas." International Journal of Molecular Sciences 21, no. 10 (2020): 3704. http://dx.doi.org/10.3390/ijms21103704.
Pełny tekst źródłaUlvmar, Maria Helena, Elin Hub, and Antal Rot. "Atypical chemokine receptors." Experimental Cell Research 317, no. 5 (2011): 556–68. http://dx.doi.org/10.1016/j.yexcr.2011.01.012.
Pełny tekst źródłaLegler, Daniel F., and Marcus Thelen. "New insights in chemokine signaling." F1000Research 7 (January 23, 2018): 95. http://dx.doi.org/10.12688/f1000research.13130.1.
Pełny tekst źródłaGencer, Selin, Emiel van der Vorst, Maria Aslani, Christian Weber, Yvonne Döring, and Johan Duchene. "Atypical Chemokine Receptors in Cardiovascular Disease." Thrombosis and Haemostasis 119, no. 04 (2019): 534–41. http://dx.doi.org/10.1055/s-0038-1676988.
Pełny tekst źródłaGustavsson, Martin, Douglas P. Dyer, Chunxia Zhao, and Tracy M. Handel. "Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding." Science Signaling 12, no. 598 (2019): eaaw3657. http://dx.doi.org/10.1126/scisignal.aaw3657.
Pełny tekst źródłaPacheco, Messias Oliveira, Fernanda Agostini Rocha, Thiago Pinheiro Arrais Aloia, and Luciana Cavalheiro Marti. "Evaluation of Atypical Chemokine Receptor Expression in T Cell Subsets." Cells 11, no. 24 (2022): 4099. http://dx.doi.org/10.3390/cells11244099.
Pełny tekst źródłaMiyabe, Yoshishige, Chie Miyabe, Vinidhra Mani, Thorsten R. Mempel, and Andrew D. Luster. "Atypical complement receptor C5aR2 transports C5a to initiate neutrophil adhesion and inflammation." Science Immunology 4, no. 35 (2019): eaav5951. http://dx.doi.org/10.1126/sciimmunol.aav5951.
Pełny tekst źródłaLeick, Marion, Julie Catusse, and Meike Burger. "The Atypical Chemokine Receptor CRAM Mediates CCL19 Transcytosis through Endothelial Cells and Modulates CCL19 Activation of Non-Hodgkin Lymphoma B Cells." Blood 114, no. 22 (2009): 2672. http://dx.doi.org/10.1182/blood.v114.22.2672.2672.
Pełny tekst źródłaChevigné, Andy, Bassam Janji, Max Meyrath, et al. "CXCL10 Is an Agonist of the CC Family Chemokine Scavenger Receptor ACKR2/D6." Cancers 13, no. 5 (2021): 1054. http://dx.doi.org/10.3390/cancers13051054.
Pełny tekst źródłaSamus, Maryna, and Antal Rot. "Atypical chemokine receptors in cancer." Cytokine 176 (April 2024): 156504. http://dx.doi.org/10.1016/j.cyto.2024.156504.
Pełny tekst źródłaBlanchet, Xavier, Christian Weber, and Philipp von Hundelshausen. "Chemokine Heteromers and Their Impact on Cellular Function—A Conceptual Framework." International Journal of Molecular Sciences 24, no. 13 (2023): 10925. http://dx.doi.org/10.3390/ijms241310925.
Pełny tekst źródłaBorroni, Elena M., Cinzia Cancellieri, Alessandro Vacchini та ін. "β-Arrestin–Dependent Activation of the Cofilin Pathway Is Required for the Scavenging Activity of the Atypical Chemokine Receptor D6". Science Signaling 6, № 273 (2013): ra30. http://dx.doi.org/10.1126/scisignal.2003627.
Pełny tekst źródłaSchlecht-Louf, Géraldine, Claire Deback, and Françoise Bachelerie. "The Chemokine System in Oncogenic Pathways Driven by Viruses: Perspectives for Cancer Immunotherapy." Cancers 14, no. 3 (2022): 848. http://dx.doi.org/10.3390/cancers14030848.
Pełny tekst źródłaMelgrati, Serena, Egle Radice, Rafet Ameti, et al. "Atlas of the anatomical localization of atypical chemokine receptors in healthy mice." PLOS Biology 21, no. 5 (2023): e3002111. http://dx.doi.org/10.1371/journal.pbio.3002111.
Pełny tekst źródłaPurvanov, Vladimir, Christoph Matti, Guerric P. B. Samson, Ilona Kindinger, and Daniel F. Legler. "Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions." International Journal of Molecular Sciences 19, no. 12 (2018): 3876. http://dx.doi.org/10.3390/ijms19123876.
Pełny tekst źródłaPatel, Manish, Iain McInnes, and Gerard Graham. "Atypical Chemokine Receptors in Inflammatory Disease." Current Molecular Medicine 9, no. 1 (2009): 86–93. http://dx.doi.org/10.2174/156652409787314480.
Pełny tekst źródłaSegerer, Stephan, Jan Jedlicka, and Rudolf P. Wüthrich. "Atypical Chemokine Receptors in Renal Inflammation." Nephron Experimental Nephrology 115, no. 4 (2010): e89-e95. http://dx.doi.org/10.1159/000313489.
Pełny tekst źródłaBachelerie, Françoise, Gerard J. Graham, Massimo Locati, et al. "New nomenclature for atypical chemokine receptors." Nature Immunology 15, no. 3 (2014): 207–8. http://dx.doi.org/10.1038/ni.2812.
Pełny tekst źródłaNibbs, Robert J. B., and Gerard J. Graham. "Immune regulation by atypical chemokine receptors." Nature Reviews Immunology 13, no. 11 (2013): 815–29. http://dx.doi.org/10.1038/nri3544.
Pełny tekst źródłaCancellieri, Cinzia, Alessandro Vacchini, Massimo Locati, Raffaella Bonecchi, and Elena M. Borroni. "Atypical chemokine receptors: from silence to sound." Biochemical Society Transactions 41, no. 1 (2013): 231–36. http://dx.doi.org/10.1042/bst20120246.
Pełny tekst źródłaTsou, Chia-Lin, Ron P. Gladue, Laurie A. Carroll, et al. "Identification of C-C Chemokine Receptor 1 (CCR1) as the Monocyte Hemofiltrate C-C Chemokine (HCC)-1 Receptor." Journal of Experimental Medicine 188, no. 3 (1998): 603–8. http://dx.doi.org/10.1084/jem.188.3.603.
Pełny tekst źródłaMackie, Duncan I., Natalie R. Nielsen, Matthew Harris, et al. "RAMP3 determines rapid recycling of atypical chemokine receptor-3 for guided angiogenesis." Proceedings of the National Academy of Sciences 116, no. 48 (2019): 24093–99. http://dx.doi.org/10.1073/pnas.1905561116.
Pełny tekst źródłaKhare, Tripti, Marc Bissonnette, and Sharad Khare. "CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies." International Journal of Molecular Sciences 22, no. 14 (2021): 7371. http://dx.doi.org/10.3390/ijms22147371.
Pełny tekst źródłaLindsay, Hunter G., Colby J. Hendrix, Josue D. Gonzalez Murcia, Christopher Haynie, and K. Scott Weber. "The Role of Atypical Chemokine Receptors in Neuroinflammation and Neurodegenerative Disorders." International Journal of Molecular Sciences 24, no. 22 (2023): 16493. http://dx.doi.org/10.3390/ijms242216493.
Pełny tekst źródłaDragan, Paulina, Matthew Merski, Szymon Wiśniewski, Swapnil Ganesh Sanmukh, and Dorota Latek. "Chemokine Receptors—Structure-Based Virtual Screening Assisted by Machine Learning." Pharmaceutics 15, no. 2 (2023): 516. http://dx.doi.org/10.3390/pharmaceutics15020516.
Pełny tekst źródłaEller, Kathrin, and Alexander R. Rosenkranz. "Atypical chemokine receptors—“chemokine PACMANs” as new therapeutic targets in glomerulonephritis." Kidney International 93, no. 4 (2018): 774–75. http://dx.doi.org/10.1016/j.kint.2017.12.021.
Pełny tekst źródłaBryce, Steven, Andrew Luster, Gerry Graham, and Rob Nibbs. "The ‘atypical’ chemokine receptor CCRL1 aids dendritic cell migration from inflamed skin. (P6352)." Journal of Immunology 190, no. 1_Supplement (2013): 199.2. http://dx.doi.org/10.4049/jimmunol.190.supp.199.2.
Pełny tekst źródłaMassara, Matteo, Ornella Bonavita, Alberto Mantovani, Massimo Locati, and Raffaella Bonecchi. "Atypical chemokine receptors in cancer: friends or foes?" Journal of Leukocyte Biology 99, no. 6 (2016): 927–33. http://dx.doi.org/10.1189/jlb.3mr0915-431rr.
Pełny tekst źródłaLe Mercier, Alan, Remy Bonnavion, Weijia Yu, et al. "GPR182 is an endothelium-specific atypical chemokine receptor that maintains hematopoietic stem cell homeostasis." Proceedings of the National Academy of Sciences 118, no. 17 (2021): e2021596118. http://dx.doi.org/10.1073/pnas.2021596118.
Pełny tekst źródłaMartini, Rachel, Petros Nikolinakos, Jamie Hodgson, Brittany Jenkins, and Melissa Davis. "The role of atypical chemokine receptor-1 in breast cancer immune response." Journal of Clinical Oncology 35, no. 15_suppl (2017): e23072-e23072. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e23072.
Pełny tekst źródłaGraham, G. J., M. Locati, A. Mantovani, A. Rot, and M. Thelen. "The biochemistry and biology of the atypical chemokine receptors." Immunology Letters 145, no. 1-2 (2012): 30–38. http://dx.doi.org/10.1016/j.imlet.2012.04.004.
Pełny tekst źródłaMajumdar, Shamik, Sergio M. Pontejo, Joseph Weaver, and Philip M. Murphy. "Ackr1-deficient mice are protected from lethal SARS-CoV-2 challenge." Journal of Immunology 210, no. 1_Supplement (2023): 79.08. http://dx.doi.org/10.4049/jimmunol.210.supp.79.08.
Pełny tekst źródłaJohnsson, H., J. Cole, G. Wilson, et al. "SAT0351 CHEMOKINE PATHWAYS ARE ENRICHED IN PSORIATIC ARTHRITIS (PSA) SKIN LESIONS WITH INCREASED EXPRESSION OF ATYPICAL CHEMOKINE RECEPTOR 2 (ACKR2)." Annals of the Rheumatic Diseases 79, Suppl 1 (2020): 1121.2–1122. http://dx.doi.org/10.1136/annrheumdis-2020-eular.2980.
Pełny tekst źródłaRusso, Remo C., Benedetta Savino, Massimiliano Mirolo та ін. "The atypical chemokine receptor ACKR2 drives pulmonary fibrosis by tuning influx of CCR2+ and CCR5+ IFNγ-producing γδT cells in mice". American Journal of Physiology-Lung Cellular and Molecular Physiology 314, № 6 (2018): L1010—L1025. http://dx.doi.org/10.1152/ajplung.00233.2017.
Pełny tekst źródłaDi Donato, Rachele, Raffaella Bonecchi, and Francesca Albano. "Canonical and atypical chemokine receptors in the neutrophil life cycle." Cytokine 169 (September 2023): 156297. http://dx.doi.org/10.1016/j.cyto.2023.156297.
Pełny tekst źródłaSinitski, Dzmitry, Christos Kontos, Christine Krammer, Yaw Asare, Aphrodite Kapurniotu, and Jürgen Bernhagen. "Macrophage Migration Inhibitory Factor (MIF)-Based Therapeutic Concepts in Atherosclerosis and Inflammation." Thrombosis and Haemostasis 119, no. 04 (2019): 553–66. http://dx.doi.org/10.1055/s-0039-1677803.
Pełny tekst źródłaCheng, Xiaoyun, and Mien-Chie Hung. "Regulation of Breast Cancer Metastasis by Atypical Chemokine Receptors: Fig. 1." Clinical Cancer Research 15, no. 9 (2009): 2951–53. http://dx.doi.org/10.1158/1078-0432.ccr-09-0141.
Pełny tekst źródłaDegroot, Gaetan-Nagim, Valentin Lepage, Marc Parmentier та Jean-Yves Springael. "The Atypical Chemerin Receptor GPR1 Displays Different Modes of Interaction with β-Arrestins in Humans and Mice with Important Consequences on Subcellular Localization and Trafficking". Cells 11, № 6 (2022): 1037. http://dx.doi.org/10.3390/cells11061037.
Pełny tekst źródłaTan, Wee Yee, Boon Yin Khoo, and Ai Lan Chew. "Pichia-Expressed Recombinant D6 and DARC Negatively Affect Cell Migration and Invasion of Breast Cancer Cells." Sains Malaysiana 50, no. 10 (2021): 3015–33. http://dx.doi.org/10.17576/jsm-2021-5010-15.
Pełny tekst źródłaPan, Li, Jianliang Lv, Zhongwang Zhang, and Yongguang Zhang. "Adaptation and Constraint in the Atypical Chemokine Receptor Family in Mammals." BioMed Research International 2018 (September 24, 2018): 1–9. http://dx.doi.org/10.1155/2018/9065181.
Pełny tekst źródłaBurger, Nathalie, Andrea Haerzschel, Marion Leick, Tanja Nicole Hartmann, Julie Catusse, and Meike Burger. "CCL19 Induced Responses Are Differentially Regulated by Atypical Chemokine Receptor CRAM and Its Classical Chemokine Receptor CCR7 in B-CLL Cells." Blood 118, no. 21 (2011): 4896. http://dx.doi.org/10.1182/blood.v118.21.4896.4896.
Pełny tekst źródłaFord, Laura B., Vuk Cerovic, Simon W. F. Milling, Gerard J. Graham, Chris A. H. Hansell, and Robert J. B. Nibbs. "Characterization of Conventional and Atypical Receptors for the Chemokine CCL2 on Mouse Leukocytes." Journal of Immunology 193, no. 1 (2014): 400–411. http://dx.doi.org/10.4049/jimmunol.1303236.
Pełny tekst źródłaCalvello, Rosa, Chiara Porro, Dario Domenico Lofrumento, Melania Ruggiero, Maria Antonietta Panaro, and Antonia Cianciulli. "Decoy Receptors Regulation by Resveratrol in Lipopolysaccharide-Activated Microglia." Cells 12, no. 5 (2023): 681. http://dx.doi.org/10.3390/cells12050681.
Pełny tekst źródłaKleist, Andrew B., Shawn Jenjak, Andrija Sente та ін. "Conformational selection guides β-arrestin recruitment at a biased G protein–coupled receptor". Science 377, № 6602 (2022): 222–28. http://dx.doi.org/10.1126/science.abj4922.
Pełny tekst źródłaDobroch, Jakub, Klaudia Bojczuk, Adrian Kołakowski, Marta Baczewska, and Paweł Knapp. "The Exploration of Chemokines Importance in the Pathogenesis and Development of Endometrial Cancer." Molecules 27, no. 7 (2022): 2041. http://dx.doi.org/10.3390/molecules27072041.
Pełny tekst źródładel Molino del Barrio, Irene, Georgina Wilkins, Annette Meeson, Simi Ali, and John Kirby. "Breast Cancer: An Examination of the Potential of ACKR3 to Modify the Response of CXCR4 to CXCL12." International Journal of Molecular Sciences 19, no. 11 (2018): 3592. http://dx.doi.org/10.3390/ijms19113592.
Pełny tekst źródłaBachelerie, Francoise, Adit Ben-Baruch, Amanda M. Burkhardt, et al. "International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors." Pharmacological Reviews 66, no. 1 (2013): 1–79. http://dx.doi.org/10.1124/pr.113.007724.
Pełny tekst źródłaKorbecki, Jan, Mateusz Bosiacki, Piotr Stasiak та ін. "Clinical Aspects and Significance of β-Chemokines, γ-Chemokines, and δ-Chemokines in Molecular Cancer Processes in Acute Myeloid Leukemia (AML) and Myelodysplastic Neoplasms (MDS)". Cancers 16, № 19 (2024): 3246. http://dx.doi.org/10.3390/cancers16193246.
Pełny tekst źródła